Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward C Spindler, BS, MBA
Whitehawk Therapeutics
Study Director - Margaret C Dugan, MD
Whitehawk Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas
Little Rock, Arkansas, United States
Michael Birrer, MDNot, yet, recruiting - Ucla - Hematology/oncology Clinical Research Unit
Los Angeles, California, United States
Aaron Lisberg, MDNot, yet, recruiting - St. Francis Medical Center (osf Healthcare)
Peoria, Illinois, United States
Michelle Rowland, MDNot, yet, recruiting - Start - Midwest
Grand Rapids, Michigan, United States
Manish SharmaRecruiting - Hackensack University Medical Center - John Theurer Cancer Center
Hackensack, New Jersey, United States
Miguel Gonzalez, MDNot, yet, recruiting - Roswell Park Comprehensive Care Center
Buffalo, New York, United States
Bailey Fitzgerald, MDNot, yet, recruiting - University Hospital - Cleveland Medical Center
Cleveland, Ohio, United States
Matthew MIrsky, MDNot, yet, recruiting - Next Oncology - Austin
Austin, Texas, United States
Recruiting - Next - Oncology - Houston
Houston, Texas, United States
Jennifer Segar, MDRecruiting - Start - San Antonio
San Antonio, Texas, United States
Recruiting - Next Oncology - Virginia Cancer Specialists
Fairfax, Virginia, United States
Alexander Spira, MD, PhDRecruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Lei Deng, MDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Dec 2025
- Primary completion
- 31 Oct 2028
- Completion
- 31 Dec 2028
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 226
- Registry id
- NCT07444814
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.